Rencilin Clayton Fernando, Chatterjee Arnab, Ansari Mohammad Yousuf, Deshpande Suprit, Mukherjee Sohini, Singh Randhir, Jayatheertha Sowrabha B, Reddy Poorvi M, Hingankar Nitin, Varadarajan Raghavan, Bhattacharya Jayanta, Dutta Somnath
Molecular Biophysics Unit, Indian Institute of Science Bengaluru 560012 India
Antibody Translational Research Program, Translational Health Science & Technology Institute Faridabad Haryana 121001 India.
RSC Adv. 2025 May 6;15(18):14385-14399. doi: 10.1039/d5ra00373c. eCollection 2025 Apr 28.
SARS-CoV-2 spike proteins play a critical role in infection by interacting with the ACE2 receptors. Their receptor-binding domains and N-terminal domains exhibit remarkable flexibility and can adopt various conformations that facilitate receptor engagement. Previous structural studies have reported the RBD of the spike protein in "up", "down", and various intermediate states, as well as its different conformational changes during ACE2 binding. This flexibility also influences its interactions with the neutralizing antibodies, yet its role in the antibody complexes remains understudied. In this study, we used cryo-electron microscopy to investigate the structural properties of two broadly neutralizing monoclonal antibodies, THSC20.HVTR04 and THSC20.HVTR26. These antibodies were isolated from an unvaccinated individual and demonstrated potent neutralization of multiple SARS-CoV-2 variants. Our analysis revealed distinct binding characteristics and conformational changes in the spike RBD upon binding with the monoclonal antibodies. The structural characterization of the spike protein-monoclonal antibody complexes provided valuable insights into the structural variability of the spike protein and the possible mechanisms for antibody-mediated neutralization.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白通过与血管紧张素转换酶2(ACE2)受体相互作用在感染过程中发挥关键作用。它们的受体结合结构域和N端结构域具有显著的灵活性,能够呈现多种构象,便于与受体结合。先前的结构研究报道了刺突蛋白的受体结合结构域处于“向上”“向下”及各种中间状态,以及其在与ACE2结合过程中的不同构象变化。这种灵活性也影响其与中和抗体的相互作用,但其在抗体复合物中的作用仍研究不足。在本研究中,我们使用冷冻电子显微镜研究了两种广泛中和的单克隆抗体THSC20.HVTR04和THSC20.HVTR26的结构特性。这些抗体是从未接种疫苗的个体中分离出来的,对多种SARS-CoV-2变体具有强效中和作用。我们的分析揭示了刺突受体结合结构域与单克隆抗体结合后独特的结合特征和构象变化。刺突蛋白-单克隆抗体复合物的结构表征为刺突蛋白的结构变异性以及抗体介导的中和作用的可能机制提供了有价值的见解。